Thomas Sproat

Tom has a broad scientific, marketing, and communications background spanning more than 25 years in the healthcare industry.

He received his Doctor of Pharmacy at the University of Florida (UF), completed a residency in adult internal medicine with an emphasis in cardiology/critical care, and wrapped up his second postdoctoral year as a teaching and research fellow in infectious diseases. He also holds a BS in medicine and a Physician Assistant Certification from the UF College of Medicine.

After completion of his postdoctoral work, Tom served as internal medicine pharmacotherapy faculty for the Family Practice Residency Program and as a clinical pharmacist at Florida Hospital Health Care System in Orlando, Florida. After a year of teaching at Auburn University School of Pharmacy, Tom joined a medical communications company, Cortex Communications, ultimately assuming the role of Chief Operating Officer.

Subsequently, Tom went inside the pharmaceutical industry. At Pharmacia, he served as a Regional Clinical Liaison, Infectious Diseases. He transitioned to the Zyvox marketing team, with primary responsibilities for opinion leader management, medical marketing, and finance. When Pharmacia was acquired, he helped launch Zyvox into the Pfizer antibiotic portfolio. Almost 2 years later, Tom transitioned to the Indiplon marketing team, where he was responsible for the managed markets launch strategy/implementation, pricing, and reimbursement, as well as operating plan and launch plan development. Finally, he served as the US commercial lead on the “clean team” during Pfizer’s acquisition of Vicuron.

Tom was a partner at Strategic HealthCOM, LLC from 2005 through 2014. His emphasis was on development of market strategy throughout the life cycle of a product (several years pre-launch through LOE), development of portfolio and co-positioning operational plans, and shepherding the development of content from CSR to publication and promotional materials to ensure consistent messaging.

Tom joined ClinicalMind in March 2014, and currently manages the Scientific and Editorial teams. Working closely with Jeanne, he has overseen the growth of his division, making strong science a pillar of what ClinicalMind has to offer.